BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7827057)

  • 1. Interconversion of the CD and EF sites in oncomodulin. Influence on the Eu3+ 7F0-->5D0 excitation spectrum.
    Kauffman JF; Hapak RC; Henzl MT
    Biochemistry; 1995 Jan; 34(3):991-1000. PubMed ID: 7827057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that deprotonation of serine-55 is responsible for the pH-dependence of the parvalbumin Eu3+ 7F0-->5D0 spectrum.
    Henzl MT; Treviño CL; Dvoráková L; Boschi JM
    FEBS Lett; 1992 Dec; 314(2):130-4. PubMed ID: 1333989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interconversion of the ligand arrays in the CD and EF sites of oncomodulin. Influence on Ca2+-binding affinity.
    Henzl MT; Hapak RC; Likos JJ
    Biochemistry; 1998 Jun; 37(25):9101-11. PubMed ID: 9636056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific substitution of glutamate for aspartate at position 59 of rat oncomodulin.
    Hapak RC; Lammers PJ; Palmisano WA; Birnbaum ER; Henzl MT
    J Biol Chem; 1989 Nov; 264(31):18751-60. PubMed ID: 2572594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eu3+ luminescence studies of oncomodulin. The origin of the pH-dependent behavior.
    Treviño CL; Palmisano WA; Birnbaum ER; Henzl MT
    J Biol Chem; 1990 Jun; 265(17):9694-700. PubMed ID: 2351666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncomodulin and parvalbumin. A comparison of their interactions with europium ion.
    Henzl MT; Birnbaum ER
    J Biol Chem; 1988 Aug; 263(22):10674-80. PubMed ID: 3392035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a high-affinity variant of rat alpha-parvalbumin.
    Lee YH; Tanner JJ; Larson JD; Henzl MT
    Biochemistry; 2004 Aug; 43(31):10008-17. PubMed ID: 15287728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of a fifth carboxylate ligand heightens the affinity of the oncomodulin CD and EF sites for Ca2+.
    Henzl MT; Hapak RC; Goodpasture EA
    Biochemistry; 1996 May; 35(18):5856-69. PubMed ID: 8639547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific replacement of amino acid residues within the CD binding loop of rat oncomodulin.
    Palmisano WA; Treviño CL; Henzl MT
    J Biol Chem; 1990 Aug; 265(24):14450-6. PubMed ID: 2387865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the metal-binding sites of cod parvalbumin using europium(III) ion luminescence and diffusion-enhanced energy transfer.
    Cronce DT; Horrocks WD
    Biochemistry; 1992 Sep; 31(34):7963-9. PubMed ID: 1510983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between residues in the oncomodulin CD domain influence Ca2+ ion-binding affinity.
    Treviño CL; Boschi JM; Henzl MT
    J Biol Chem; 1991 Jun; 266(17):11301-8. PubMed ID: 2040635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics study of Ca(2+) binding loop variants of silver hake parvalbumin with aspartic acid at the "gateway" position.
    Fahie K; Pitts R; Elkins K; Nelson DJ
    J Biomol Struct Dyn; 2002 Apr; 19(5):821-37. PubMed ID: 11922838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Europium(III) ion luminescence as a structural probe of parvalbumin isotypes.
    McNemar CW; Horrocks WD
    Biochim Biophys Acta; 1990 Sep; 1040(2):229-36. PubMed ID: 2400774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of rat α-parvalbumin: replacement of canonical CD-site residues with their non-consensus counterparts from rat β-parvalbumin.
    Henzl MT; Sirianni AG; Markus LA; Davis CM
    Biophys Chem; 2015 Feb; 197():25-39. PubMed ID: 25553513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanthanide-binding properties of rat oncomodulin.
    Henzl MT; Hapak RC; Birnbaum ER
    Biochim Biophys Acta; 1986 Jul; 872(1-2):16-23. PubMed ID: 3730394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential influence of Asp in the Ca2+ coordination position 5 of parvalbumin on the calcium-binding affinity: a computational study.
    Zhao J; Nelson DJ; Huo S
    J Inorg Biochem; 2006 Nov; 100(11):1879-87. PubMed ID: 16965819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific replacement of amino acid residues in the CD site of rat parvalbumin changes the metal specificity of this Ca2+/Mg(2+)-mixed site toward a Ca(2+)-specific site.
    Pauls TL; Durussel I; Clark ID; Szabo AG; Berchtold MW; Cox JA
    Eur J Biochem; 1996 Dec; 242(2):249-55. PubMed ID: 8973640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics study of Ca(2+) binding loop variants of parvalbumin with modifications at the "gateway" position.
    Elkins KM; Gatzeva-Topalova PZ; Nelson DJ
    Protein Eng; 2001 Feb; 14(2):115-26. PubMed ID: 11297669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of the AB site of rat parvalbumin and oncomodulin into a canonical EF-hand.
    Cox JA; Durussel I; Scott DJ; Berchtold MW
    Eur J Biochem; 1999 Sep; 264(3):790-9. PubMed ID: 10491125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncomodulin. 1H NMR and optical stopped-flow spectroscopic studies of its solution conformation and metal-binding properties.
    Williams TC; Corson DC; Sykes BD; MacManus JP
    J Biol Chem; 1987 May; 262(13):6248-56. PubMed ID: 3571255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.